Serina Therapeutics Income Statement (2017-2025) | SER

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & Cost
Revenue (Quarter) 0.46M0.23M0.23M0.39M0.38M0.41M0.55M0.09M0.04M0.07M0.16M0.06M0.04M0.02M0.03M0.01M0.01M0.01M0.01M0.03M0.01M0.03M3.09M0.01M0.05M0.01M-0.01M0.13M
Interest income
Interest Income - Total (Quarter) 0.09M0.06M0.05M0.07M
Interest expenses
Interest Expenses (Quarter) 0.28M0.29M0.57M0.86M0.92M0.98M0.09M0.11M0.10M0.18M0.19M0.31M0.02M0.02M0.01M0.01M0.20M
Interest Income - Net (Quarter) -0.10M-0.25M0.05M0.06M
Operating Items
Research & Development (Quarter) 1.38M1.33M1.52M1.34M1.65M1.45M1.47M1.22M0.94M0.65M0.91M0.32M0.48M0.28M0.38M0.40M0.26M0.16M0.21M0.40M0.48M0.60M0.91M1.11M1.59M2.42M2.37M2.95M3.15M3.65M3.40M
Selling, General & Administrative (Quarter) 1.14M1.25M1.97M2.11M2.12M2.19M1.72M1.88M1.48M1.80M1.57M2.02M1.75M1.42M1.52M1.66M1.34M1.39M1.58M0.59M0.47M0.89M1.94M1.22M2.32M2.91M3.17M2.91M2.54M2.74M2.81M
Other Operating Expenses (Quarter) -5.17M-6.98M-6.89M
Operating Expenses (Quarter) 2.52M-2.59M-3.49M-3.45M3.77M3.64M3.19M3.10M2.41M2.45M2.48M2.35M2.23M1.70M1.89M2.06M1.60M1.55M1.79M0.99M0.95M1.49M2.85M2.33M3.92M5.33M5.54M5.86M5.70M6.39M6.21M
Operating Income (Quarter) -2.13M-2.20M-3.36M-3.12M-3.44M-3.28M-2.72M-3.01M-2.37M-2.40M-2.33M-2.19M-2.21M-1.67M-1.87M-2.05M-1.59M-1.55M-1.78M-0.96M-0.94M-1.46M0.24M-2.32M-3.87M-5.31M-5.55M-5.86M-5.57M-6.39M-6.21M
EBIT (Quarter) -2.13M-2.20M-3.36M-3.12M-3.44M-3.28M-2.72M-3.01M-2.37M-2.40M-2.33M-2.19M-2.21M-1.67M-1.87M-2.05M-1.59M-1.55M-1.78M-0.96M-0.94M-1.46M0.24M-2.32M-3.87M-5.31M-5.55M-5.86M-5.57M-6.39M-6.21M
Non-operating items
Interest & Investment Income (Quarter) 0.03M0.04M0.03M0.01M0.03M0.01M-0.02M-0.03M-0.07M-0.13M-0.18M-0.24M-0.27M-0.28M-0.29M-0.57M-0.86M
Other Non Operating Income (Quarter) 0.16M-0.02M0.05M-0.03M0.26M0.05M0.02M0.01M0.00M-0.01M0.10M0.44M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.10M0.09M0.09M0.06M0.04M0.04M0.05M0.07M0.04M-0.10M
Non Operating Income (Quarter) 0.18M0.02M0.08M-0.03M0.26M0.06M-0.04M0.01M0.00M-0.13M-0.08M0.44M0.00M-0.28M-0.29M-0.66M-1.03M-0.89M-0.98M2.62M1.75M0.10M8.20M-12.69M9.04M6.70M-2.82M1.04M0.07M1.80M4.67M
Net income details
EBT (Quarter) -1.95M-2.19M-3.27M-3.14M-3.15M-3.22M-2.72M-3.03M-2.43M-2.52M6.22M-1.99M-2.48M-1.96M-2.26M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M
Tax Provisions (Quarter) 0.07M0.00M0.05M0.02M
Profit After Tax (Quarter) -1.95M-2.19M-3.19M-3.13M-3.15M-3.28M-2.51M-3.22M-2.69M0.00M-1.98M0.00M0.00M-1.96M-2.17M-2.71M-2.62M-2.44M-2.76M1.66M0.81M1.75M1.05M-15.02M5.18M1.41M-2.69M-4.82M-6.46M-4.59M-3.34M
Income from Non-Controlling Interests (Quarter) -0.02M-0.03M-0.09M-0.08M-0.07M-0.06M-0.03M-0.04M-0.04M-0.02M-0.01M-0.01M-0.00M-0.00M-0.06M-0.01M-0.01M-0.03M-0.03M-0.01M-0.01M-0.01M-0.01M
Income from Continuing Operations (Quarter) -1.95M-2.19M-3.27M-3.21M-3.15M-3.28M-2.74M-3.03M-2.43M-2.52M6.22M-1.99M-2.48M-1.96M-2.26M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M
Consolidated Net Income (Quarter) -1.95M-2.19M-3.27M-3.21M-3.15M-3.28M-2.74M-0.19M-0.30M-0.02M-0.29M-0.10M-0.01M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M
Income towards Parent Company (Quarter) -1.95M-2.19M-3.27M-3.21M-3.15M-3.28M-2.74M-0.19M-0.30M-0.02M-0.29M-0.10M-0.01M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M
Net Income towards Common Stockholders (Quarter) -1.95M-2.19M-3.27M-3.21M-3.15M-3.28M-2.74M-0.19M-0.30M-0.02M-0.29M-0.10M-0.01M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M-6.41M
Additional items
EPS (Basic) (Quarter) -0.01-0.06-0.06-0.09-0.09-0.08-0.09-0.08-0.08-0.06-0.07-0.07-0.05-0.07-0.05-0.06-0.07-0.07-0.06-9.500.770.370.800.42-5.380.610.16-0.27-0.49-0.66-0.45-0.31
EPS (Weighted Average and Diluted) (Quarter) 0.00-0.07-0.07-0.06-9.500.200.110.230.16-5.380.510.13-0.27-0.49-0.66-0.45-0.31
Shares Outstanding (Weighted Average) (Quarter) 30.64M33.75M34.23M0.03M34.91M0.04M37.63M0.04M37.27M37.65M37.65M37.68M37.67M37.73M0.04M37.87M37.89M2.66M2.50M0.04M0.36M2.17M0.36M2.18M2.23M2.79M8.51M8.85M7.36M9.76M10.00M10.03M10.19M
Shares Outstanding (Diluted Average) (Quarter) 37.73M37.94M0.04M0.04M0.00M8.57M0.01M7.58M7.35M2.79M10.16M6.77M7.36M9.76M10.00M10.03M10.19M
EBITDA (Quarter) -2.13M-2.20M-3.36M-3.12M-3.44M-3.28M-2.72M-3.01M-2.37M-2.40M-2.33M-2.19M-2.21M-1.67M-1.87M-2.05M-1.59M-1.55M-1.78M-0.96M-0.94M-1.46M0.24M-2.32M-3.87M1.38M-5.55M-5.86M-5.57M-4.60M-6.21M
Tax Rate (Quarter) -2.33%-0.10%-1.68%-0.66%